Rua Bioscience Limited (NZE:RUA)
New Zealand · Delayed Price · Currency is NZD 0.0400
-0.0020 (-4.76%)
Jul 14, 2026, 12:48 PM NZST
Rua Bioscience Market Cap
Rua Bioscience has a market cap or net worth of 14.26 million as of July 13, 2026. Its market cap has increased by 165.61% in one year.
Market Cap
14.26M
Enterprise Value
13.90M
Revenue
2.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since October 22, 2020, Rua Bioscience's market cap has decreased from 95.21M to 14.26M, a decrease of -85.03%. That is a compound annual growth rate of -28.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 14.26M | 50.62% |
| Dec 31, 2025 | 9.47M | 54.80% |
| Dec 31, 2024 | 6.11M | -67.78% |
| Dec 29, 2023 | 18.98M | -44.14% |
| Dec 30, 2022 | 33.97M | -45.52% |
| Dec 31, 2021 | 62.37M | -25.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fisher & Paykel Healthcare Corporation | 23.64B |
| EBOS Group | 4.58B |
| Ryman Healthcare | 2.19B |
| Summerset Group Holdings | 2.13B |
| Pacific Edge | 353.93M |
| Green Cross Health | 287.43M |
| Radius Residential Care | 107.72M |
| Third Age Health Services | 45.79M |